cached image

A. Richard Chamberlin - Publications

Chemistry University of California, Irvine, Irvine, CA 
Organic Synthesis, Chemical Biology

98 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Woydziak ZR, Yucel AJ, Chamberlin AR. Tautomycetin Synthetic Analogues: Selective Inhibitors of Protein Phosphatase I. Chemmedchem. PMID 33301228 DOI: 10.1002/cmdc.202000801  1
2015 Kaur P, Chamberlin R, Poulos TL, Sevrioukova IF. Structure-based inhibitor design for evaluation of a CYP3A4 pharmacophore model. Journal of Medicinal Chemistry. PMID 26371436 DOI: 10.1021/acs.jmedchem.5b01146  1
2015 Glauber KM, Dana CE, Park SS, Colby DA, Noro Y, Fujisawa T, Chamberlin AR, Steele RE. A small molecule screen identifies a novel compound that induces a homeotic transformation in Hydra. Development (Cambridge, England). 142: 2081. PMID 26015540 DOI: 10.1242/dev.126235  1
2015 Zhu J, Chen H, Guo XE, Qiu XL, Hu CM, Chamberlin AR, Lee WH. Synthesis, molecular modeling, and biological evaluation of novel RAD51 inhibitors. European Journal of Medicinal Chemistry. 96: 196-208. PMID 25874343 DOI: 10.1016/j.ejmech.2015.04.021  1
2015 Hu CM, Zhu J, Guo XE, Chen W, Qiu XL, Ngo B, Chien R, Wang YV, Tsai CY, Wu G, Kim Y, Lopez R, Chamberlin AR, Lee EY, Lee WH. Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. Oncogene. 34: 1220-30. PMID 24662830 DOI: 10.1038/onc.2014.67  1
2013 Glauber KM, Dana CE, Park SS, Colby DA, Noro Y, Fujisawa T, Chamberlin AR, Steele RE. A small molecule screen identifies a novel compound that induces a homeotic transformation in Hydra. Development (Cambridge, England). 140: 4788-96. PMID 24255098 DOI: 10.1242/dev.094490  1
2013 Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E, Bhatia R, Chamberlin AR, Chen PL, Lee WH. A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. Embo Molecular Medicine. 5: 353-65. PMID 23341130 DOI: 10.1002/emmm.201201760  1
2011 Delisle Milton RC, Milton SC, Chamberlin AR. Improving the Fmoc Solid Phase Synthesis of the Cyclic Hexapeptide Complement C5a Antagonist, PMX205. International Journal of Peptide Research and Therapeutics. 17: 337-342. PMID 22707924 DOI: 10.1007/s10989-011-9273-9  1
2011 Mihailescu M, Vaswani RG, Jardón-Valadez E, Castro-Román F, Freites JA, Worcester DL, Chamberlin AR, Tobias DJ, White SH. Acyl-chain methyl distributions of liquid-ordered and -disordered membranes. Biophysical Journal. 100: 1455-62. PMID 21402027 DOI: 10.1016/j.bpj.2011.01.035  1
2010 Limon A, Reyes-Ruiz JM, Vaswani RG, Chamberlin AR, Miledi R. Kaitocephalin antagonism of glutamate receptors expressed in Xenopus oocytes. Acs Chemical Neuroscience. 1: 175-181. PMID 20436943 DOI: 10.1021/cn900037c  1
2010 Habay SA, Park SS, Kennedy SM, Chamberlin AR. Methods for the Chemical Synthesis of Noncoded α-Amino Acids found in Natural Product Peptides Amino Acids, Peptides and Proteins in Organic Chemistry. 1: 163-243. DOI: 10.1002/9783527631766.ch5  1
2009 Qiu XL, Li G, Wu G, Zhu J, Zhou L, Chen PL, Chamberlin AR, Lee WH. Synthesis and biological evaluation of a series of novel inhibitor of Nek2/Hec1 analogues. Journal of Medicinal Chemistry. 52: 1757-67. PMID 19243176 DOI: 10.1021/jm8015969  1
2009 Vaswani RG, Limon A, Reyes-Ruiz JM, Miledi R, Chamberlin AR. Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (-)-kaitocephalin. Bioorganic & Medicinal Chemistry Letters. 19: 132-5. PMID 19017555 DOI: 10.1016/j.bmcl.2008.11.004  1
2008 Okamura N, Habay SA, Zeng J, Chamberlin AR, Reinscheid RK. Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor. The Journal of Pharmacology and Experimental Therapeutics. 325: 893-901. PMID 18337476 DOI: 10.1124/jpet.107.135103  1
2008 Tappan E, Chamberlin AR. Activation of protein phosphatase 1 by a small molecule designed to bind to the enzyme's regulatory site. Chemistry & Biology. 15: 167-74. PMID 18291321 DOI: 10.1016/j.chembiol.2008.01.005  1
2008 Vaswani RG, Chamberlin AR. Stereocontrolled total synthesis of (--)-kaitocephalin. The Journal of Organic Chemistry. 73: 1661-81. PMID 18225916 DOI: 10.1021/jo702329z  1
2007 Cohen JL, Chamberlin AR. Diastereoselective synthesis of glutamate-appended oxolane rings: synthesis of (s)-(+)-lycoperdic acid. The Journal of Organic Chemistry. 72: 9240-7. PMID 17975930 DOI: 10.1021/jo7017137  1
2007 Cohen JL, Chamberlin AR. Synthesis of the dysiherbaine tetrahydropyran core employing a tethered aminohydroxylation reaction. Tetrahedron Letters. 48: 2533-2536. PMID 17479167 DOI: 10.1016/j.tetlet.2007.02.016  1
2006 Colby DA, Chamberlin AR. Pharmacophore identification: the case of the ser/thr protein phosphatase inhibitors. Mini Reviews in Medicinal Chemistry. 6: 657-65. PMID 16787376 DOI: 10.2174/138955706777435715  1
2006 Charvat TT, Lee DJ, Robinson WE, Chamberlin AR. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase. Bioorganic & Medicinal Chemistry. 14: 4552-67. PMID 16524737 DOI: 10.1016/j.bmc.2006.02.030  1
2006 Cohen JL, Limon A, Miledi R, Chamberlin AR. Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (-)-dysiherbaine. Bioorganic & Medicinal Chemistry Letters. 16: 2189-94. PMID 16455241 DOI: 10.1016/j.bmcl.2006.01.047  1
2006 Alexander MD, Burkart MD, Leonard MS, Portonovo P, Liang B, Ding X, Joullié MM, Gulledge BM, Aggen JB, Chamberlin AR, Sandler J, Fenical W, Cui J, Gharpure SJ, Polosukhin A, et al. A central strategy for converting natural products into fluorescent probes. Chembiochem : a European Journal of Chemical Biology. 7: 409-16. PMID 16432909 DOI: 10.1002/cbic.200500466  1
2005 Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ. The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3. Neuropharmacology. 49: 850-61. PMID 16183084 DOI: 10.1016/j.neuropharm.2005.08.009  1
2005 Shou X, Miledi R, Chamberlin AR. Indole- and indoline-based kainate analogues with antagonist activity at ionotropic glutamate receptors. Bioorganic & Medicinal Chemistry Letters. 15: 3942-7. PMID 16005214 DOI: 10.1016/j.bmcl.2005.05.098  1
2005 Sandler JS, Fenical W, Gulledge BM, Chamberlin AR, La Clair JJ. Fluorescent profiling of natural product producers. Journal of the American Chemical Society. 127: 9320-1. PMID 15984830 DOI: 10.1021/ja042756u  1
2004 Hart ME, Chamberlin AR, Walkom C, Sakoff JA, McCluskey A. Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. Bioorganic & Medicinal Chemistry Letters. 14: 1969-73. PMID 15050639 DOI: 10.1016/j.bmcl.2004.01.093  1
2004 Shou X, Chamberlin AR. Ligands for kainate subtype glutamate receptors Expert Opinion On Therapeutic Patents. 14: 471-486. DOI: 10.1517/13543776.14.4.471  1
2003 Gulledge BM, Aggen JB, Eng H, Sweimeh K, Chamberlin AR. Microcystin analogues comprised only of Adda and a single additional amino acid retain moderate activity as PP1/PP2A inhibitors. Bioorganic & Medicinal Chemistry Letters. 13: 2907-11. PMID 14611855 DOI: 10.1016/S0960-894X(03)00588-2  1
2003 Gulledge BM, Aggen JB, Chamberlin AR. Linearized and truncated microcystin analogues as inhibitors of protein phosphatases 1 and 2A. Bioorganic & Medicinal Chemistry Letters. 13: 2903-6. PMID 14611854 DOI: 10.1016/S0960-894X(03)00589-4  1
2003 Colby DA, Liu W, Sheppeck JE, Huang HB, Nairn AC, Chamberlin AR. A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structure. Bioorganic & Medicinal Chemistry Letters. 13: 1601-5. PMID 12699764 DOI: 10.1016/S0960-894X(03)00106-9  1
2003 Liu W, Sheppeck JE, Colby DA, Huang HB, Nairn AC, Chamberlin AR. The selective inhibition of phosphatases by natural toxins: the anhydride domain of tautomycin is not a primary factor in controlling PP1/PP2A selectivity. Bioorganic & Medicinal Chemistry Letters. 13: 1597-600. PMID 12699763 DOI: 10.1016/S0960-894X(03)00105-7  1
2002 Gulledgea BM, Aggena JB, Huangb HB, Nairnc AC, Chamberlin AR. The microcystins and nodularins: cyclic polypeptide inhibitors of PP1 and PP2A. Current Medicinal Chemistry. 9: 1991-2003. PMID 12369867  1
2002 Lew A, Chamberlin AR. The preparation of phenyl-stilbene derivatives using the safety catch linker. Methods in Molecular Biology (Clifton, N.J.). 201: 93-109. PMID 12357941 DOI: 10.1385/1-59259-285-6:93  1
2002 Krutzik PO, Chamberlin AR. Synthesis of DNA-binding polyamides. Robust solid-phase methods for coupling heterocyclic aromatic amino acids. Methods in Molecular Biology (Clifton, N.J.). 201: 77-92. PMID 12357940 DOI: 10.1385/1-59259-285-6:77  1
2002 Esslinger CS, Titus J, Koch HP, Bridges RJ, Chamberlin AR. Methylation of l-trans-2,4-pyrrolidine dicarboxylate converts the glutamate transport inhibitor from a substrate to a non-substrate inhibitor Bioorganic and Medicinal Chemistry. 10: 3509-3515. PMID 12213465 DOI: 10.1016/S0968-0896(02)00250-X  1
2002 Krutzik PO, Chamberlin AR. Rapid solid-phase synthesis of DNA-binding pyrrole-imidazole polyamides. Bioorganic & Medicinal Chemistry Letters. 12: 2129-32. PMID 12127520 DOI: 10.1016/S0960-894X(02)00359-1  1
2002 Phillips D, Chamberlin AR. Total synthesis of dysiherbaine. The Journal of Organic Chemistry. 67: 3194-201. PMID 12003525 DOI: 10.1021/jo0107610  1
2002 Lew A, Krutzik PO, Hart ME, Chamberlin AR. Increasing rates of reaction: microwave-assisted organic synthesis for combinatorial chemistry. Journal of Combinatorial Chemistry. 4: 95-105. PMID 11886281  1
2001 Anderson CM, Bridges RJ, Chamberlin AR, Shimamoto K, Yasuda-Kamatani Y, Swanson RA. Differing effects of substrate and non-substrate transport inhibitors on glutamate uptake reversal. Journal of Neurochemistry. 79: 1207-16. PMID 11752061 DOI: 10.1046/j.1471-4159.2001.00668.x  1
2000 Lew A, Chamberlin AR. Human T-cell Kv1.3 potassium channel blockers: New strategies for immunosuppression Expert Opinion On Therapeutic Patents. 10: 905-915.  1
1999 Lew A, Chamberlin AR. Blockers of human T cell Kv1.3 potassium channels using de novo ligand design and solid-phase parallel combinatorial chemistry. Bioorganic & Medicinal Chemistry Letters. 9: 3267-72. PMID 10612582  1
1999 Koch HP, Kavanaugh MP, Esslinger CS, Zerangue N, Humphrey JM, Amara SG, Chamberlin AR, Bridges RJ. Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters. Molecular Pharmacology. 56: 1095-104. PMID 10570036  1
1999 Koch HP, Chamberlin AR, Bridges RJ. Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult. Molecular Pharmacology. 55: 1044-8. PMID 10347246  1
1999 Aggen JB, Humphrey JM, Gauss CM, Huang HB, Nairn AC, Chamberlin AR. The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity. Bioorganic & Medicinal Chemistry. 7: 543-64. PMID 10220039 DOI: 10.1016/S0968-0896(98)00254-5  1
1999 Bridges RJ, Kavanaugh MP, Chamberlin AR. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. Current Pharmaceutical Design. 5: 363-79. PMID 10213800  1
1998 Esslinger CS, Koch HP, Kavanaugh MP, Philips DP, Chamberlin AR, Thompson CM, Bridges RJ. Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate. Bioorganic & Medicinal Chemistry Letters. 8: 3101-6. PMID 9873684 DOI: 10.1016/S0960-894X(98)00560-5  1
1998 Chamberlin AR, Koch HP, Bridges RJ. Design and synthesis of conformationally constrained inhibitors of high-affinity, sodium-dependent glutamate transporters. Methods in Enzymology. 296: 175-89. PMID 9779448 DOI: 10.1016/S0076-6879(98)96014-1  1
1998 Steward LE, Chamberlin AR. Protein engineering with nonstandard amino acids. Methods in Molecular Biology (Clifton, N.J.). 77: 325-54. PMID 9770680 DOI: 10.1385/0-89603-397-X:325  1
1997 Humphrey JM, Chamberlin AR. Chemical Synthesis of Natural Product Peptides: Coupling Methods for the Incorporation of Noncoded Amino Acids into Peptides. Chemical Reviews. 97: 2243-2266. PMID 11848900  1
1997 Sheppeck JE, Liu W, Chamberlin AR. Total Synthesis of the Serine/Threonine-Specific Protein Phosphatase Inhibitor Tautomycin(1). The Journal of Organic Chemistry. 62: 387-398. PMID 11671414 DOI: 10.1021/jo961633s  1
1997 Sheppeck JE, Gauss CM, Chamberlin AR. Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins. Bioorganic & Medicinal Chemistry. 5: 1739-50. PMID 9354230 DOI: 10.1016/S0968-0896(97)00146-6  1
1997 Willis CL, Dauenhauer DL, Humphrey JM, Chamberlin AR, Buller AL, Monaghan DT, Bridges RJ. Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: enhanced excitotoxic potency and selectivity. Toxicology and Applied Pharmacology. 144: 45-55. PMID 9169068 DOI: 10.1006/taap.1997.8112  1
1997 Steward LE, Collins CS, Gilmore MA, Carlson JE, Ross JBA, Chamberlin AR. In vitro site-specific incorporation of fluorescent probes into β-galactosidase Journal of the American Chemical Society. 119: 6-11. DOI: 10.1021/ja963023f  1
1997 Wacker DA, Lovering FE, Bridges RJ, Willis C, Bartlett R, Chamberlin AR. A selective photoaffinity ligand for the kainate class of excitatory amino acid receptor Synlett. 503-504.  1
1996 Willis CL, Humphrey JM, Koch HP, Hart JA, Blakely T, Ralston L, Baker CA, Shim S, Kadri M, Chamberlin AR, Bridges RJ. L-trans-2,3-pyrrolidine dicarboxylate: characterization of a novel excitotoxin. Neuropharmacology. 35: 531-9. PMID 8887961 DOI: 10.1016/0028-3908(96)84623-5  1
1996 Humphrey JM, Aggen JB, Chamberlin AR. Total synthesis of the serine-threonine phosphatase inhibitor microcystin-LA Journal of the American Chemical Society. 118: 11759-11770. DOI: 10.1021/ja961683e  1
1996 Sonnenberg JD, Koch HP, Willis CL, Bradbury P, Dauenhauer D, Bridges RJ, Chamberlin AR. The role of the C-4 side chain of kainate and dihydrokainate in EAA receptor and transporter selectivity Bioorganic and Medicinal Chemistry Letters. 6: 1607-1612. DOI: 10.1016/S0960-894X(96)00284-3  1
1995 Canan Koch SS, Chamberlin AR. Enantiomerically pure γ-butyrolactones in natural products synthesis Studies in Natural Products Chemistry. 16: 687-725. DOI: 10.1016/S1572-5995(06)80065-7  1
1994 Bridges RJ, Lovering FE, Koch H, Cotman CW, Chamberlin AR. A conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: L-anti-endo-3,4-methanopyrrolidine dicarboxylate. Neuroscience Letters. 174: 193-7. PMID 7970177 DOI: 10.1016/0304-3940(94)90019-1  1
1994 Miller S, Bridges RJ, Chamberlin AR, Cotman CW. Pharmacological dissociation of glutamatergic metabotropic signal transduction pathways in cortical astrocytes. European Journal of Pharmacology. 269: 235-41. PMID 7851499 DOI: 10.1016/0922-4106(94)90091-4  1
1994 Augeri DJ, Chamberlin AR. N-Aminoaziridinylhydrazones: Highly diastereoselective alkylation without chelation, and a syn-directing effect Tetrahedron Letters. 35: 5599-5602. DOI: 10.1016/S0040-4039(00)77256-X  1
1994 Humphrey JM, Bridges RJ, Hart JA, Chamberlin AR. 2,3-Pyrrolidinedicarboxylates as neurotransmitter conformer mimics: Enantioselective synthesis via chelation-controlled enolate alkylation Journal of Organic Chemistry. 59: 2467-2472.  1
1994 Cristofaro MF, Chamberlin AR. Enantioselective and diastereoselective molecular recognition of cyclic dipeptides by a C2 macrolactam host Journal of the American Chemical Society. 116: 5089-5098.  1
1993 Bridges RJ, Lovering FE, Humphrey JM, Stanley MS, Blakely TN, Cristofaro MF, Chamberlin AR. Conformationally restricted inhibitors of the high affinity L-glutamate transporter Bioorganic and Medicinal Chemistry Letters. 3: 115-121. DOI: 10.1016/S0960-894X(00)80103-1  1
1993 Canan Koch SS, Chamberlin AR. Enantioselective preparation of β-alkyl-γ-butyrolactones from functionalized ketene dithioacetals Journal of Organic Chemistry. 58: 2725-2737.  1
1992 Bain JD, Switzer C, Chamberlin AR, Benner SA. Ribosome-mediated incorporation of a non-standard amino acid into a peptide through expansion of the genetic code. Nature. 356: 537-9. PMID 1560827 DOI: 10.1038/356537a0  1
1991 Bain JD, Diala ES, Glabe CG, Wacker DA, Lyttle MH, Dix TA, Chamberlin AR. Site-specific incorporation of nonnatural residues during in vitro protein biosynthesis with semisynthetic aminoacyl-tRNAs. Biochemistry. 30: 5411-21. PMID 2036409  1
1991 Bridges RJ, Stanley MS, Anderson MW, Cotman CW, Chamberlin AR. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. Journal of Medicinal Chemistry. 34: 717-25. PMID 1671706 DOI: 10.1021/JM00106A037  1
1991 Leone CL, Chamberlin AR. Lithium aluminum hydride reduction of N-aziridinylimines to hydrocarbons Tetrahedron Letters. 32: 1691-1694. DOI: 10.1016/S0040-4039(00)74305-X  1
1991 Bain JD, Wacker DA, Kuo EE, Chamberlin AR. Site-specific incorporation of non-natural residues into peptides: Effect of residue structure on suppression and translation efficiencies Tetrahedron. 47: 2389-2400. DOI: 10.1016/S0040-4020(01)81776-2  1
1991 Bain JD, Wacker DA, Kuo EE, Lyttle MH, Chamberlin AR. Preparation of chemically misacylated semisynthetic nonsense suppressor tRNAs employed in biosynthetic incorporation of non-natural residues into proteins Journal of Organic Chemistry. 56: 4615-4625.  1
1991 Lyttle MH, Wright PB, Sinha ND, Bain JD, Chamberlin AR. New nucleoside phosphoramidites and coupling protocols for solid-phase RNA synthesis Journal of Organic Chemistry. 56: 4608-4615.  1
1991 Fotsch CH, Chamberlin AR. Stereochemical control in reactions of nucleophiles with oxocarbenium ions formed by intramolecular opening of activated epoxides by neighboring carbonyl groups Journal of Organic Chemistry. 56: 4141-4147.  1
1990 Miller SA, Chamberlin AR. Enantiomerically pure polyhydroxylated acyliminium ions. Synthesis of the glycosidase inhibitors (-)-swainsonine and (+)-castanospermine Journal of the American Chemical Society. 112: 8100-8112.  1
1989 Chamberlin AR, Dezube M, Reich SH, Sall DJ. Enantioselective total synthesis of 9S-dihydroerythronolide A seco acid Journal of the American Chemical Society. 111: 6247-6256.  1
1989 Bain JD, Glabe CG, Dix TA, Chamberlin AR, Diala ES. Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide Journal of the American Chemical Society. 111: 8013-8014.  1
1989 Miller SA, Chamberlin AR. Highly selective formation of cis-substituted hydroxylactams via auxiliary-controlled reduction of imides Journal of Organic Chemistry. 54: 2502-2504.  1
1988 Dodge JA, Chamberlin AR. Competitive Dienone-Phenol Type Rearrangements for the RegioselectivePreparation of 2,4-Disubstituted-Naphth-1-ols Tetrahedron Letters. 29: 4827-4830. DOI: 10.1016/S0040-4039(00)80619-X  1
1988 Dodge JA, Chamberlin AR. Synthesis and rotational barriers of aryl-substituted naphthacenesystems: Framework for a receptor model Tetrahedron Letters. 29: 1359-1362. DOI: 10.1016/S0040-4039(00)80296-8  1
1988 Chamberlin AR, Bloom SH, Cervini LA, Fotsch CH. Vinyllithium cyclizations with unactivated alkenes as internal electrophiles: Stereoselective formation of substituted methylenecyclopentanes Journal of the American Chemical Society. 110: 4788-4796.  1
1988 Mulholland RL, Chamberlin AR. Stereochemical control in the synthesis of 2,5-disubstituted tetrahydrofurans Journal of Organic Chemistry. 53: 1082-1085.  1
1987 Chamberlin AR, Mulholland RL, Kahn SD, Hehre WJ. Modeling chemical reactivity. 7. The effect of a change in rate-limiting step on the stereoselectivity of electrophilic addition to allylic alcohols and related chiral alkenes Journal of the American Chemical Society. 109: 672-677.  1
1987 Kahn SD, Pau CF, Chamberlin AR, Hehre WJ. Modeling chemical reactivity. 4. Regiochemistry and stereochemistry of electrophilic additions to allylic double bonds Journal of the American Chemical Society. 109: 650-663.  1
1986 Chamberlin AR, Bloom SH. Stereoselective formation of a hydrindane ring system by anionic olefin cyclization. Trapping of the alkyllithium intermediate with electrophiles Tetrahedron Letters. 27: 551-554. DOI: 10.1016/S0040-4039(00)84037-X  1
1986 Chamberlin AR, Nguyen H. Lithiation of 2-bromoketene dithioacetals Journal of Organic Chemistry. 51: 940-941.  1
1985 Chamberlin AR, Chung JYL. Enantioselective synthesis of seven pyrrolizidine diols from a single precursor Journal of Organic Chemistry. 50: 4425-4431.  1
1985 Chamberlin AR, Reich SH. Stereoselective acyclic enolate formation via conjugate reduction: Correlation with enone conformational preferences Journal of the American Chemical Society. 107: 1440-1441.  1
1984 Chamberlin AR, Bloom SH. Cyclizations of alkenyllithium reagents Tetrahedron Letters. 25: 4901-4904. DOI: 10.1016/S0040-4039(01)91254-7  1
1983 Monaghan DT, McMills MC, Chamberlin AR, Cotman CW. Synthesis of [3H]2-amino-4-phosphonobutyric acid and characterization of its binding to rat brain membranes: a selective ligand for the chloride/calcium-dependent class of L-glutamate binding sites. Brain Research. 278: 137-44. PMID 6640305 DOI: 10.1016/0006-8993(83)90232-9  1
1983 Chamberlin AR, Chung JYL. Synthesis of optically active pyrrolizidinediols: (+)-heliotridine Journal of the American Chemical Society. 105: 3653-3656.  1
1982 Chamberlin AR, Dezube M. Stereoselective methylation of β-hydroxylactone dianions Tetrahedron Letters. 23: 3055-3058. DOI: 10.1016/S0040-4039(00)87531-0  1
1982 Chamberlin AR, Chung JYL. The ketene thioacetal group as a cationic cyclization terminator. A synthesis of the pyrrolizidine ring system Tetrahedron Letters. 23: 2619-2622. DOI: 10.1016/S0040-4039(00)87412-2  1
1981 Chamberlin AR, Dezube M, Dussault P. Stereoselective iodolactonization of acyclic unsaturated 3-hydroxyacids Tetrahedron Letters. 22: 4611-4614. DOI: 10.1016/S0040-4039(01)82994-4  1
1980 Corey EJ, Weigel LO, Chamberlin AR, Lipshutz B. Total synthesis of (-)-N-methylmaysenine [16] Journal of the American Chemical Society. 102: 1439-1441.  1
1978 Chamberlin AR, Stemke JE, Bond FT. Vinyllithium reagents from arenesulfonylhydrazones Journal of Organic Chemistry. 43: 147-154.  1
1978 Chamberlin AR, Bond FT. Leaving-group variation in aprotic Bamford-Stevens carbene generation Journal of Organic Chemistry. 43: 154-155.  1
1976 Stemke JE, Chamberlin AR, Bond FT. A convenient route to vinyllithium reagents Tetrahedron Letters. 17: 2947-2950. DOI: 10.1016/S0040-4039(01)85496-4  1
Show low-probability matches.